March 21, 2024

Arthritis Advisory Committee Roster

Applying for Membership on FDA Advisory Committees As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of […]
March 20, 2024

Pyramid Wholesale Issues Recall of Various Brands of Products Sold as Dietary Supplements for Sexual Enhancement Because They Contain Undeclared Prescription Drugs Including Sildenafil (Viagra) and/or Tadalafil (Cialis)

Summary Company Announcement Date: March 19, 2024 FDA Publish Date: March 20, 2024 Product Type: Dietary SupplementsDrugs Reason for Announcement: Recall Reason Description Undeclared Sildenafil and/or […]
March 20, 2024

Regulatory Policy Information

Date Issued Type Title Statements 3/19/2024 Proposed Rule Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0